How do you pay?

How to pay the least

Cash price

$3,670+ for 30 tablets

Pharmacies pay about this for Symbravo; you’d pay more.

  1. Ask your pharmacy for Symbravo’s cash price, and one or two other pharmacies too.
  2. Symbravo’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameSymbravo
Authorized genericmeloxicam and rizatriptan
Regular genericmeloxicam and rizatriptan
What you’d pay
At least$3,670for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Symbravo?
The original
–
–

Brand nameThe maker’s card

SYMBRAVO OnMySide Savings Program

Savings card from Axsome Therapeutics

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on symbravo.com 

See the offer on symbravo.com

In the maker’s words

“Pay as little as $0 a month for your prescription…”

From the maker’s offer on symbravo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Symbravo itself, from the same company, sold without the brand name, and usually for less. For now Symbravo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SYMBRAVO is a combination of meloxicam (an NSAID) and rizatriptan (a serotonin (5-HT) 1B/1D receptor agonist (triptan)), indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use

  • SYMBRAVO should only be used where a clear diagnosis of migraine has been established.
  • SYMBRAVO is not indicated for the preventive treatment of migraine.
  • SYMBRAVO is not indicated for the treatment of cluster headache.

Source: the FDA label for Symbravo (Axsome Therapeutics, Inc.), October 8, 2026. Full label on DailyMed 

Good to know